Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLYCOPAR: Glycopyrrolate for Sialorrhea in PD
NCT02382198Phase 2Unknown
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jul 2016
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of glycopyrronium in sialorrhea (2 arms), sponsored by Ottawa Hospital Research Institute. Primary endpoint: Radboud Oral Motor Inventory for Parkinson's Disease-Saliva at 90 days. Status: unknown.
02
Drugs
glycopyrronium
03
Conditions
sialorrhea
Beyond the preview
Go deeper on NCT02382198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02382198.